Clinical Trial Update: A Study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Patients Undergoing Major Surgery. [Phase 3]

View source ↗

Summary

Phase 3 trial update for Replenine-VF in haemophilia B patients undergoing major surgery; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilia

Drugs mentioned

• Replenine®-VF (Factor IX concentrate)

Snippet

Sponsor: Bio Products Laboratory | Conditions: Haemophilia B | Phase 3 | Status: COMPLETED